These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28916623)

  • 1. Efficacy of Radioembolization with
    Prince JF; van den Bosch MAAJ; Nijsen JFW; Smits MLJ; van den Hoven AF; Nikolakopoulos S; Wessels FJ; Bruijnen RCG; Braat MNGJA; Zonnenberg BA; Lam MGEH
    J Nucl Med; 2018 Apr; 59(4):582-588. PubMed ID: 28916623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
    Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holmium-166 Microsphere Radioembolization of Hepatic Malignancies.
    Reinders MTM; Smits MLJ; van Roekel C; Braat AJAT
    Semin Nucl Med; 2019 May; 49(3):237-243. PubMed ID: 30954190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-effect relationships in neuroendocrine tumour liver metastases treated with [
    Ramdhani K; Beijer-Verduin J; Ebbers SC; van Rooij R; Smits MLJ; Bruijnen RCG; de Jong HWAM; Lam MGEH; Braat AJAT
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2114-2123. PubMed ID: 38369678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Evidence for a Dose-Response Relationship in Patients Treated with
    Bastiaannet R; van Roekel C; Smits MLJ; Elias SG; van Amsterdam WAC; Doan D; Prince JF; Bruijnen RCG; de Jong HWAM; Lam MGEH
    J Nucl Med; 2020 Apr; 61(4):608-612. PubMed ID: 31601696
    [No Abstract]   [Full Text] [Related]  

  • 6. Additional hepatic
    Braat AJAT; Kwekkeboom DJ; Kam BLR; Teunissen JJM; de Herder WW; Dreijerink KMA; van Rooij R; Krijger GC; de Jong HWAM; van den Bosch MAAJ; Lam MGEH
    BMC Gastroenterol; 2018 Jun; 18(1):84. PubMed ID: 29902988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies.
    Smits ML; Elschot M; van den Bosch MA; van de Maat GH; van het Schip AD; Zonnenberg BA; Seevinck PR; Verkooijen HM; Bakker CJ; de Jong HW; Lam MG; Nijsen JF
    J Nucl Med; 2013 Dec; 54(12):2093-100. PubMed ID: 24136931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study.
    Braat AJAT; Bruijnen RCG; van Rooij R; Braat MNGJA; Wessels FJ; van Leeuwaarde RS; van Treijen MJC; de Herder WW; Hofland J; Tesselaar MET; de Jong HWAM; Lam MGEH
    Lancet Oncol; 2020 Apr; 21(4):561-570. PubMed ID: 32112737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice.
    Radosa CG; Radosa JC; Grosche-Schlee S; Zöphel K; Plodeck V; Kühn JP; Kotzerke J; Hoffmann RT
    Cardiovasc Intervent Radiol; 2019 Mar; 42(3):405-412. PubMed ID: 30603976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Effect Relationships of
    van Roekel C; Bastiaannet R; Smits MLJ; Bruijnen RC; Braat AJAT; de Jong HWAM; Elias SG; Lam MGEH
    J Nucl Med; 2021 Feb; 62(2):272-279. PubMed ID: 32591491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of
    Reinders MTM; van Erpecum KJ; Smits MLJ; Braat AJAT; Bruijne J; Bruijnen R; Sprengers D; Man RA; Vegt E; IJzermans JNM; Moelker A; Lam MGEH
    J Nucl Med; 2022 Dec; 63(12):1891-1898. PubMed ID: 35589409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.
    Elschot M; Nijsen JF; Lam MG; Smits ML; Prince JF; Viergever MA; van den Bosch MA; Zonnenberg BA; de Jong HW
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
    Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT
    AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
    J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
    Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
    J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
    J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
    Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H
    J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
    Klingenstein A; Haug AR; Zech CJ; Schaller UC
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-Response and Dose-Toxicity Relationships for Glass
    Alsultan AA; van Roekel C; Barentsz MW; Smits MLJ; Kunnen B; Koopman M; Braat AJAT; Bruijnen RCG; de Keizer B; Lam MGEH
    J Nucl Med; 2021 Nov; 62(11):1616-1623. PubMed ID: 33741643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
    Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H
    J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.